Sanofi India Standalone December 2023 Net Sales at Rs 693.90 crore, up 3.27% Y-o-Y
26-02-2024
Sanofi India Ltd - 500674 - Record Date For Interim And Final Dividend
The Record date for the Interim Dividend shall be 7th March, 2024 and for the Final Dividend shall be 3rd May, 2024.23-02-2024
Sanofi India Ltd - 500674 - Corporate Action-Board approves Dividend
The Board, at its meeting held on 23rd February, 2024, has declared an Interim Dividend of Rs. 50 per equity share and recommended a Final Dividend of Rs. 117 per equity share.23-02-2024
Sanofi India Ltd - 500674 - Announcement under Regulation 30 (LODR)-Dividend Updates
The Board, at its meeting held on 23rd February, 2024, has declared an Interim Dividend of Rs. 50 per equity share and recommended a Final Dividend of Rs. 117 per equity share. Kindly refer the attachment for further details on payment date.23-02-2024
Sanofi India Ltd - 500674 - Board Meeting Outcome for Board Meeting Outcome For Standalone And Consolidated Financial Results For The Quarter And Year Ended 31St December 2023
We enclose a copy of the Auditor''s report and Audited Standalone and Consolidated Financial Results of the Company for the Financial Year ended 31st December 2023 along with Statement of Assets and Liabilities as on that date and Statement of Cashflows for the year ended 31st December 2023 as required under Regulation 33 of the SEBI (listing Obligations and Disclosure Requirements) Regulations, 2015. Further, the Board has also declared an Interim Dividend of Rs. 50 per equity share and recommended a final dividend of Rs. 117 per equity share.23-02-2024
Sanofi India Ltd - 500674 - Standalone And Consolidated Financial Results Of The Company For The Quarter And Year Ended 31St December 2023
We enclose a copy of the Auditor''s Report and Audited Standalone and Consolidated Financial Results of the Company for the Financial Year ended 31st December 2023 along with the statement of assets and liabilities and statement of cashflows as on that date as required under Regulation 33 of the SEBI (LODR) Regulations, 2015.23-02-2024
Sanofi India Ltd - 500674 - Clarification Regarding Appointment Of Independent Directors By Sanofi Consumer Healthcare India Limited
We wish to clarify that each of the said appointments of Independent Directors of Sanofi Consumer Healthcare India Limited, a wholly owned subsidiary of the Company, are effective from 1st March 2024, for a term of five years.22-02-2024
Sanofi India Ltd - 500674 - Appointment Of Independent Directors By Wholly Owned Subsidiary (Sanofi Consumer Healthcare)
Please find enclosed intimation from Sanofi Consumer Healthcare India Limited made to the Company disclosing the appointment of Independent Directors each for a term of five years.21-02-2024
Advent, Blackstone Among Suitors Circling $20 Billion Sanofi Arm
Some of the world's largest buyout firms, including Advent International and Blackstone Group Inc., are circling the consumer health division of French pharmaceutical giant Sanofi ahead of a potential separation of the business, according to people familiar with the matter.20-02-2024
Sanofi India Ltd - 500674 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Please find enclosed copies of the Notice to Shareholders of the Company published today, in newspapers, Business Standard and Sakal.20-02-2024